bindarit has been researched along with Neointima in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Kilari, S; Misra, S; Singh, AK | 1 |
| Baker, AH; Biondi, G; Colombo, A; Di Lauro, MV; Gordon, P; Grassia, G; Guglielmotti, A; Ialenti, A; Kennedy, S; Maddaluno, M; Maffia, P | 1 |
| Cicala, C; De Filippis, D; Di Lauro, MV; Grassia, G; Guglielmotti, A; Ialenti, A; Iuvone, T; Maddaluno, M; Maffia, P; Maione, F; Mascolo, N; Parisi, A | 1 |
3 other study(ies) available for bindarit and Neointima
| Article | Year |
|---|---|
Bindarit encapsulated nanoparticles prevent venous neointimal hyperplasia and restenosis in a murine angioplasty model.
Topics: Angioplasty; Animals; Arteriovenous Fistula; Chromatography, Liquid; Constriction, Pathologic; Disease Models, Animal; Hyperplasia; Indazoles; Mice; Nanoparticles; Neointima; Propionates; Renal Dialysis; Tandem Mass Spectrometry | 2022 |
Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries.
Topics: Administration, Oral; Animals; Cell Proliferation; Coronary Stenosis; Coronary Vessels; Indazoles; Male; Models, Animal; Monocyte Chemoattractant Proteins; Muscle, Smooth, Vascular; Neointima; Propionates; Stents; Swine; Treatment Outcome | 2011 |
Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching.
Topics: Actins; Animals; Calcium-Binding Proteins; Calponins; Cell Differentiation; Cell Movement; Cell Proliferation; Coronary Vessels; Gene Expression; Humans; Indazoles; Microfilament Proteins; Monocyte Chemoattractant Proteins; Myocytes, Smooth Muscle; Myosin Heavy Chains; Neointima; Propionates; Rats | 2012 |